1. Academic Validation
  2. Sphaeralcic acid and tomentin, anti-inflammatory compounds produced in cell suspension cultures of Sphaeralcea angustifolia

Sphaeralcic acid and tomentin, anti-inflammatory compounds produced in cell suspension cultures of Sphaeralcea angustifolia

  • Planta Med. 2014 Feb;80(2-3):209-14. doi: 10.1055/s-0033-1360302.
Juanita Pérez-Hernández 1 Manasés González-Cortazar 1 Silvia Marquina 2 Maribel Herrera-Ruiz 1 Mariana Meckes-Fischer 3 Jaime Tortoriello 1 Francisco Cruz-Sosa 4 María del Pilar Nicasio-Torres 1
Affiliations

Affiliations

  • 1 Centro de Investigación Biomédica del Sur (CIBIS), Instituto Mexicano del Seguro Social (IMSS), Xochitepec, Morelos, México.
  • 2 Centro de Investigaciones Químicas (CIQ), Universidad Autónoma del Estado de Morelos (UAEM), Cuernavaca, Morelos, México.
  • 3 Unidad de Investigación Médica en Farmacología de Productos Naturales, Instituto Mexicano del Seguro Social (UIMFPN-IMSS), Hospital de Pediatría, Centro Médico Nacional Siglo XXI (CMN-SXXI), Ciudad de México, México.
  • 4 Departamento de Biotecnología, Universidad Autónoma Metropolitana Unidad Iztapalapa (UAM-Iztapalapa), Ciudad de México, México.
Abstract

Sphaeralcea angustifolia, an endangered plant species in Mexico, is employed to treat inflammatory processes and as a wound healing remedy. Scopoletin (1) was reported as one of the main bioactive compounds in this plant. Here, we isolated and identified compounds with anti-inflammatory properties from the suspension-cultured cells of S. angustifolia. The CH2Cl2 : CH3OH extract of the cells exhibited anti-inflammatory properties in acute inflammation models. Two compounds were isolated, 5-hydroxy-6,7-dimethoxycoumarin, named tomentin (2), and 2-(1,8-dihydroxy-4-isopropyl-6-methyl-7-methoxy)-naphthoic acid, denominated as sphaeralcic acid (3). Their structures were determined by spectroscopic and spectrometric analyses. The anti-inflammatory effects of both compounds were also evaluated. At a dose of 45 mg/kg, compound 2 inhibited the formation of λ-carrageenan footpad edema at 58 %, and compound 3 at 66 %. Local application of compound 2 (225 mM per ear) or 3 (174 mM per ear) inhibited the phorbol ester-induced auricular edema formation by 57 % or 86 %, respectively. The effect of compound 3 was dose-dependent and the ED50 was 93 mM.

Figures
Products